Oxurion NV - Ordinary Shares


By |


ThromboGenics NV is a Belgium based biopharmaceutical corporation. It is primarily focused on developing and commercializing treatments for back of the eye disease, with a focus on diabetic eye disease.

Contact Information

Website: www.oxurion.com
Email: chris.buyse@thrombogenics.com
Main Phone: +32 16751310
Address: Gaston Geenslaan 1
City / Town: Leuven
Country: BEL
Postal Code: B-3001

Issuer Information

Exchange: OTO
Employees: 80
$ 5.69 $ 0. (0.00%)
Last Price 5.69 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 5.69
Last Trade Volume 0 52 Wk Hi 9.20 52 Wk Low 3.95
Market Cap 217.8 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 38,271,575.00 EPS (TTM) 0.77 PE Ratio 7.40 Exchange OTCPK